Study brings insight to kidney cancer with gene mutation

Researchers studied over 800 clinical assays of renal cancer with a specific genetic mutation, the largest series of its kind

5:00 AM

Author | Anna Megdell

gloved hand doing microplate samples
Getty Images

A study from clinicians and researchers at the University of Michigan Rogel Cancer Center, U-M Department of Pathology and the Michigan Center for Translational Pathology reveals findings from over 800 clinical assays performed for kidney patients with MiTF family gene mutations.

The study, published in the American Journal of Clinical Pathology¸ is the largest series of its kind in kidney cancer and carries deep clinical and diagnostics implications.

The team, led by Rohit Mehra, M.D., performed over 800 clinical assays on the MiTF family genes TFE3 and TFEB in renal tumors with morphologic and biomarker alterations considered suspicious for MiTF family genetic mutations.

The findings show that the patients who had renal tumors with TFEB amplification were significantly older than patients with renal tumors housing TFE3 or TFEB translocation.

Further, renal tumors with TFEB amplification, known to be associated with poor prognosis, were seen to be at least three times as common as those with TFEB translocation.

Mehra says these assays are the gold standard for diagnosing MiTF mutated renal cell carcinoma.

“These findings give us a comprehensive picture of the molecular landscape of renal tumors with MiTF family aberrations,” said Mehra.

“Renal cell carcinoma prognosis and personalized therapy can be heavily influenced by renal tumor subtyping, and these FISH assays are crucial towards identifying such genomic aberrations.”

These assays help accurately categorize patients with the MiTF mutation into three genomic categories: TFE3 translocation, TFEB translocation and TFEB amplification.

This knowledge adds further understanding to the complexities in kidney cancer disease, and can help provide researchers and clinical teams with deeper diagnostic, prognostic and clinical insight.

Additional authors include Xiao-Ming Wang, Ph.D., Lina Shao, M.D., Ph.D., Hong Xiao, Ph.D., Jeffrey L Myers, M.D., Liron Pantanowitz, M.D., Stephanie L Skala, M.D., Aaron M Udager, M.D., Ph.D., Ulka Vaishampayan, MBBS, Rahul Mannan, M.D., Saravana M Dhanasekaran, Ph.D., Arul M Chinnaiyan, M.D., Ph.D., Bryan L Betz, Ph.D., Noah Brown, M.D.

Paper cited: “Lessons from 801 clinical TFE3/TFEB fluorescence in situ hybridization assays performed on renal cell carcinoma suspicious for MiTF family aberrations,” American Journal of Clinical Pathology. DOI: 10.1093/ajcp/aqad089


More Articles About: All Research Topics Cancer Research Cancer and Genetics Kidney Disease Kidney Cancer
Health Lab word mark overlaying blue cells
Health Lab

Explore a variety of healthcare news & stories by visiting the Health Lab home page for more articles.

Media Contact Public Relations

Department of Communication at Michigan Medicine

[email protected]

734-764-2220

Stay Informed

Want top health & research news weekly? Sign up for Health Lab’s newsletters today!

Subscribe
Featured News & Stories smart watch on wrist
Health Lab
Clinical smart watch finds success at identifying atrial fibrillation
A Michigan Medicine research team developed a prescription wristwatch that continuously monitors the wearer’s heart rhythm and uses a unique algorithm to detect atrial fibrillation. The clinical-grade device, called the Verily Study Watch, proved very accurate at identifying atrial fibrillation in participants.
sketched out bacteria in a dish yellow and blue colors of U-M
Health Lab
This gross mixture has big benefits for the study of bacteria
Michigan Medicine researchers have found that growing bacteria on agar mixed with organs is an efficient and effective way to study infectious pathogens.
green blue map of michigan
Health Lab
How does exposure to ‘forever chemicals’ impact your cancer risk
Pearce, professor of epidemiology at the School of Public Health and co-lead of Rogel’s cancer control and population sciences program, reflects on the project and why bringing this study to Michigan is so critical.
A family discussing their family's medical history at Thanksgiving
Health Lab
Why you need to discuss your family health history at Thanksgiving
The holidays are a great time to discuss your family's medical history. Learn the importance of discussing your family's health history & how to bring it up.
supar molecule teal blue yellow red
Health Lab
Immune protein suPAR links viral infection as possible cause of kidney disease
Through a series of experiments in non-human primates, mice and humans, a multi-institutional team led by researchers from Michigan Medicine and Rush University found that the immune protein soluble urokinase plasminogen activator receptor, or suPAR, is an important link between viral infections and proteinuria; the elevation of protein in the urine is known to cause glomerulopathy, a common form of kidney disease.
person holding walker with nurse next to them closer up on hands lower body
Health Lab
Long COVID happens in nursing homes, too
Post-acute sequelae of Sars-COV2 (PASC, long COVID) caused a decrease in independence and cognitive ability after coronavirus infection in nursing home residents